Align Technology, Inc. (ALGN) Stock Score, Valuation & Financial Research
Align Technology, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 42/100.
Quick answer for ALGN
Align Technology, Inc. currently has a Wall Street Score of 42/100. The stored market price is $150.82. Its financial score is 44/100. Its valuation score is 16/100. The latest WSS change is +0.5 points. These figures are a research snapshot, not a buy or sell recommendation.
What Align Technology, Inc. does
Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to
ALGN financial snapshot
- Wall Street Score:
- 42/100
- Current price:
- $150.82
- Market capitalization:
- $10.80B
- Revenue:
- $4.14B
- Net income:
- $413.6M
- Free cash flow:
- $490.8M
- Cash:
- $1.10B
- Total debt:
- $120.8M
- EPS:
- 5.76
- P/E ratio:
- 26.2x
- Financial score:
- 44/100
- Valuation score:
- 16/100
- Revenue score:
- 16/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $490.8M, showing positive cash generation.
- The balance sheet shows $1.10B of cash versus $120.8M of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +0.5 points: ALGN increased 0.5 points because Capital improved by 2 points, Valuation improved by 2.4 points.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 44/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-08.
How to research ALGN
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.